Study | Reason for exclusion |
---|---|
Benitez 2010 | Randomised clinical trial comparing RATG with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Boillot 2005 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Cosimi 1987 | Randomised clinical trial comparing muromonab CD3 with glucocorticosteroids for treatment of acute rejection; no comment on glucocorticosteroid avoidance or withdrawal possible |
Cuervas‐Mons 2009 | Randomised clinical trial comparing mycophenolate mofetil with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Day 2004 | Randomised clinical trial comparing continuation of tacrolimus monotherapy with tacrolimus discontinuation and replacement with mycophenolate mofetil and glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
De Simone 2007 | Randomised clinical trial comparing basiliximab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Filipponi 2004 | Method reports study as a randomised clinical trial with ITT. Results are reported instead as a per‐treatment analysis with patients moved between arms for analysis as a result of a data‐dependent process. This does not appear to have been carried out using pre‐specified criteria. Our inclusion criteria state that we are only considering randomised clinical trials that present their data in an ITT analysis for this review. We made attempts to contact the author to request the original data so that ITT analysis could be completed. |
Foroncewicz 2009 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Ganschow 2007 | Randomised clinical trial comparing high‐ and low‐dose glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Hu 2013 | Non‐randomised clinical trial comparing multiple immunosuppression regimens |
Jonas 2001 | Randomised clinical trial comparing tacrolimus‐based dual therapy with cyclosporine A‐based quadruple therapy in which glucocorticosteroid withdrawal was assessed as an outcome; no comment on glucocorticosteroid avoidance or withdrawal possible |
Junge 2005 | Randomised clinical trial comparing mycophenolate mofetil with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Kato 2007 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Klintmalm 2011 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Lupo 2008 | Randomised clinical trial comparing basiliximab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Manousou 2009 | Randomised clinical trial comparing monotherapy of tacrolimus with triple therapy of tacrolimus, azathioprine and glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
McDiarmid 1995 | Randomised clinical trial comparing glucocorticosteroid continuation with glucocorticosteroid withdrawal over 1 year post‐transplant; investigation of alteration in an existing immunosuppression strategy rather than a primary immunosuppression strategy |
Nair 2006 | Randomised clinical trial comparing RATG with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Nair 2008 | Randomised clinical trial comparing PEG interferon alpha 2b, ribavirin and amantadine with PEG interferon alpha 2b and ribavirin in 2 glucocorticosteroid‐free arms; no comment on glucocorticosteroid avoidance or withdrawal possible |
Neumann 2012 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Otero 2009 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Saliba 2012 | Randomised clinical trial comparing concentration‐controlled mycophenolate mofetil with fixed‐dose mycophenolate mofetil and glucocorticosteroids; differences in concomitant immunosuppression therefore no comment on glucocorticosteroid avoidance or withdrawal possible |
Spada 2006 | Randomised clinical trial comparing basiliximab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Takada 2013 | Randomised clinical trial comparing mycophenolate mofetil with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Teisseyre 2006 | Randomised clinical trial comparing saline with methylprednisolone for prevention of ischaemia reperfusion injury; no comment on glucocorticosteroid avoidance or withdrawal for post‐transplantation immunosuppression possible |
Turner 2006 | Randomised clinical trial comparing RATG with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
Washburn 2001 | Randomised clinical trial comparing daclizumab with glucocorticosteroids; no comment on glucocorticosteroid avoidance or withdrawal possible |
ITT: intention‐to‐treat Muromonab CD3: muromonab cluster of differentiation 3 PEG: pegylated RATG: rabbit antithymocyte globulin